COGT
Cogent Biosciences, Inc.
Stock
$31.02−0.57 (−1.80%)Close Oct 2, 2026
- Operating cash flow, 2025
- −$264M
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | −$264M | — |
| 2024 | −$208M | — |
| 2023 | −$154M | — |
| 2022 | −$119M | — |
| 2021 | −$59M | — |
| 2020 | −$36M | — |
| 2019 | −$42M | — |
| 2018 | −$32M | — |
| 2017 | −$26M | — |